Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,980 | 21,470 | N/A | 19,580 | N/A |
| Receivables | 3,220 | 920 | N/A | 1,700 | N/A |
| Inventories | 140 | 0 | N/A | 190 | N/A |
| Other current assets | 2,040 | 460 | 470 | 110 | 0 |
| TOTAL | $17,380 | $22,850 | $470 | $21,580 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,020 | 2,470 | N/A | 1,420 | N/A |
| Other Non-Current Assets | 0 | 13,330 | 14,780 | 0 | 0 |
| TOTAL | $3,020 | $15,800 | $14,780 | $1,420 | $N/A |
| Total Assets | $20,410 | $38,660 | $15,250 | $23,010 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,970 | 4,970 | 4,220 | 1,600 | 0 |
| Other current liabilities | 1,920 | 1,020 | 430 | 4,310 | N/A |
| TOTAL | $7,890 | $6,000 | $4,650 | $5,980 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $2,090 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,990 | $6,000 | $4,650 | $5,980 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 222,830 | 201,960 | 216,580 | 182,750 | N/A |
| Retained earnings | -241,690 | -195,290 | N/A | -185,100 | N/A |
| Other shareholders' equity | 10 | 0 | 0 | 10 | 0 |
| TOTAL | $10,420 | $32,660 | $244,210 | $17,020 | $N/A |
| Total Liabilities And Equity | $20,410 | $38,660 | $248,860 | $23,000 | $0 |